|
| 32348764 | Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross. | Cell Rep | 2020 |
| 29187420 | Bayesian Diallel Analysis Reveals <i>Mx1</i>-Dependent and <i>Mx1</i>-Independent Effects on Response to Influenza A Virus in Mice. | G3 (Bethesda) | 2018 |
| 30301856 | Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. | mBio | 2018 |
| 29540599 | Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform. | J Virol | 2018 |
| 29324290 | Ross River virus envelope glycans contribute to disease through activation of the host complement system. | Virology | 2018 |
| 29138302 | Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology. | mBio | 2017 |
| 26015500 | Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection. | mBio | 2015 |
| 26491151 | γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease. | J Virol | 2015 |
| 26452100 | Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. | PLoS Genet | 2015 |
| 24667706 | A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. | mBio | 2014 |
| 25266735 | A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. | Cancer Discov | 2014 |
| 24902603 | Genomic profiling of collaborative cross founder mice infected with respiratory viruses reveals novel transcripts and infection-related strain-specific gene and isoform expression. | G3 (Bethesda) | 2014 |
| 23487448 | Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. | J Virol | 2013 |
| 23468633 | Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. | PLoS Pathog | 2013 |
| 22384400 | Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice. | G3 (Bethesda) | 2012 |
| 22837203 | Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice. | J Virol | 2012 |
| 22531556 | Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles. | Vaccine | 2012 |
| 22457620 | Mannose binding lectin is required for alphavirus-induced arthritis/myositis. | PLoS Pathog | 2012 |
| 20980507 | Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus. | J Virol | 2011 |
| 21849461 | The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection. | J Virol | 2011 |
| 21937658 | A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. | J Virol | 2011 |
| 21224040 | A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. | Am J Pathol | 2011 |
| 20386712 | SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. | PLoS Pathog | 2010 |
| 20181704 | T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody. | J Virol | 2010 |
| 19225006 | Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. | J Virol | 2009 |
| 19656875 | Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff. | J Virol | 2009 |
| 19793821 | Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. | J Virol | 2009 |
| 19171081 | An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus. | Epidemiol Infect | 2009 |
| 17904185 | Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine. | Virology | 2008 |
| 18566424 | Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node. | J Immunol | 2008 |
| 18582997 | Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen. | Vaccine | 2008 |
| 18656518 | The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines. | Vaccine | 2008 |
| 17275057 | Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles. | Virology | 2007 |
| 17913817 | Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. | J Virol | 2007 |
| 17652394 | An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. | J Virol | 2007 |
| 16378976 | Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. | J Virol | 2006 |
| 17194199 | Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. | PLoS Med | 2006 |
| 16505353 | Mucosal and systemic adjuvant activity of alphavirus replicon particles. | Proc Natl Acad Sci U S A | 2006 |
| 15494487 | Rapid induction of splenic and peritoneal B-1a cells in adult mice by thymus-independent type-2 antigen. | J Immunol | 2004 |
| 8671640 | Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. | Int Immunol | 1996 |
| 7680563 | B-1 cells are made, not born. | Immunol Today | 1993 |
| 1376029 | Isotype switching in CD5 B cells. | Ann N Y Acad Sci | 1992 |
| 2049338 | Ig isotype switching in B lymphocytes. The effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma. | Int Immunol | 1991 |
| 2489041 | Ig isotype switching in B lymphocytes. A method for estimating isotype switch frequency in cloned B cell lymphomas. | Int Immunol | 1989 |
| 3131432 | Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM. | J Immunol | 1988 |
| 2987113 | Subline divergence within L.C. Strong's C3H and CBA inbred mouse strains. A review. | Immunogenetics | 1985 |
| 6308100 | Rous sarcoma virus-induced tumours in mice. II. Contribution of H-2 and non-H-2 alloantigen barriers to tumour immunogenicity in vivo. | J Immunogenet | 1983 |
| 6284517 | Rous sarcoma virus-induced tumors in mice--I. Macrophage-mediated natural cytotoxicity. | Eur J Cancer Clin Oncol | 1982 |
| 6982816 | Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells. | Eur J Immunol | 1982 |
| 6167622 | Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: cross-reactivity of the H-2Kbm1 through Kbm4 H-2 mutant alleles in Kb-restricted SV40-specific killing. | J Immunol | 1981 |